Management of stable angina
A Jain1, V Wadehra, A D Timmis
1London Chest Hospital, London, UK. ajay106@hotmail.com
Insights
Managing chronic stable angina involves treating co-existing conditions, modifying risk factors, and relieving symptoms. While lifestyle changes and certain medications offer proven benefits, optimal strategies for risk stratification and treatment remain under investigation for ischemic heart disease.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Background:
- Ischemic heart disease, encompassing conditions like angina pectoris and myocardial infarction, presents a significant health burden.
- Chronic stable angina is a prevalent condition affecting individuals and society, necessitating effective management strategies.
Purpose of the Study:
- To outline the multifaceted goals in managing chronic stable angina.
- To review current understanding and evidence gaps in risk stratification and treatment strategies for angina.
- To emphasize the importance of lifestyle modifications and evidence-based therapies.
Main Methods:
- Review of existing literature on the management of ischemic heart disease and chronic stable angina.
- Analysis of the evidence base for various therapeutic interventions, including lifestyle modifications, pharmacotherapy, angioplasty, and coronary artery bypass surgery.
- Assessment of risk stratification methods and their limitations.
Main Results:
- Lifestyle modification and attention to modifiable risk factors are paramount for improving outcomes.
- Lipid-lowering treatment and antiplatelet therapy demonstrate proven mortality benefits.
- Angioplasty offers symptomatic relief but no mortality benefit, whereas coronary artery bypass surgery reduces mortality in severe coronary disease.
Conclusions:
- Optimal treatment strategies for chronic stable angina require further clarification, particularly regarding risk stratification.
- Evidence for anti-anginal therapies is less robust than for therapies improving overall outcome.
- Coronary artery bypass surgery is indicated for mortality reduction in specific patient populations with severe coronary artery disease.
Abstract:
Ischaemic heart disease may present as a wide variety of clinical entities including unstable or stable angina pectoris, acute myocardial infarction, and occasionally heart failure. Chronic stable angina is a common condition and results in a considerable burden for both the individual and society. The goals in management are (i) treatment of other conditions that may worsen angina; (ii) modification of risk factors and treatment with medications for coronary artery disease to improve outcome; and (iii) effective relief of anginal symptoms. There are limitations to the methods available to risk-stratify patients, and the optimal treatment strategy remains unclear. The benefits of lifestyle modification cannot be over-emphasised, and appropriate attention to modifiable risk factors is paramount. The mortality benefit of lipid lowering treatment and antiplatelet therapy is well proved. However the evidence base for anti-ischaemic therapy is less rigorous, being based mainly on extrapolations from studies of acute coronary syndromes. Angioplasty has been shown to be more effective in relief of symptoms than medical therapy alone, but provides no mortality benefit. Coronary artery bypass surgery, however, has been shown to reduce mortality in patients with severe proximal coronary disease when compared with medical management alone.
Related Concept Videos
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Acute Coronary Syndrome IV: Interprofessional Care
Angina II: Classification
Angina III: Clinical Manifestations and Assessment
Angina IV: Management
Angina V: Nursing Management


